4//SEC Filing
Kelly James Patrick 4
Accession 0001104659-24-033163
CIK 0001000694other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 9:39 PM ET
Size
11.2 KB
Accession
0001104659-24-033163
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Kelly James Patrick
EVP, CFO and Treasurer
Transactions
- Exercise/Conversion
Common Stock
2024-03-07+12,224→ 16,808 total - Tax Payment
Common Stock
2024-03-07$5.61/sh−5,905$33,127→ 10,903 total - Exercise/Conversion
Restricted Stock Units
2024-03-07−12,224→ 24,446 total→ Common Stock (12,224 underlying) - Award
Restricted Stock Units
2023-09-12−35,000→ 35,000 total→ Common Stock (35,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F2]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest in full as of December 31, 2024, subject to continued employment through such vesting date.
- [F3]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001506314
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 9:39 PM ET
- Size
- 11.2 KB